Abstract
The present review summarizes the knowledge about a protein-interaction network, which includes proteins with significant functions in the mechanisms of aging and age-related diseases. All the detected interacting proteins TPPII, p53, MYBBP1A, CDK2 and SIRT7, SIRT6, and CD147 are suitable for the development of antitumor therapeutics and treatments for diseases of aging. TPPII and SIRT6 directly affect glucose metabolism which drive malignant growth. In addition, SIRT6 activators are attractive candidates for Alzheimer’s disease (AD) due to the protection effect of SIRT6 overexpression from DNA damage. TPPII activity exhibits a decreasing effect on mTOR signaling, and its requirement for the degradation of Aβ peptides in the human fibroblasts suggests that it has dual functions in tumorigenesis and AD-related pathology. Likewise, the direct promotion of the invasiveness of breast epithelial cells and the contribution to the Aβ degradation by stimulating the matrix metalloproteinases production suggest a double functional role for CD147. An association of the partial portion of cellular CD147 to γ-secretase further supports the functional relation to AD pathology. The animal and cellular models with downregulated or knockout TPPII, p53, SIRT6, SIRT7, and MYBBP1A expression levels illustrate similar functions of the interacting proteins. They demonstrate similar effects on the length of life span, premature aging, and lipid metabolism. The presented protein-interaction network is relevant to the discoveries of the mechanisms of tumorigenesis, aging, and neurodegeneration.
Similar content being viewed by others
References
McKay RM, McKay JP, Suh JM, Avery L, Graff JM (2007) Tripeptidyl peptidase II promotes fat formation in a conserved fashion. EMBO Rep 8:1183–1189
Firat E, Tsurumi C, Gaedicke S, Huai J, Niedermann G (2009) Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization. Cancer Res 69:3325–3331
Huai J, Firat E, Nil A, Million D et al (2008) Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice. Proc Natl Acad Sci USA 105:5177–5182
Hilbi H, Puro RJ, Zychlinsky A (2000) Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis. Infect Immun 68:5502–5508
Zhang J, Wong J, Gao G, Luo H (2011) Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells. FEBS Lett 585:261–265
Wiemhoefer A, Stargardt A, van der Linden WA, Renner MC et al (2015) Tripeptidyl peptidase II mediates levels of nuclear phosphorylated ERK1 and ERK2. Mol Cell Proteomics. doi:10.1074/mcp.M114.043331
Stavropoulou V, Vasquez V, Cereser B, Freda E, Masucci MG (2006) TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints. Biochem Biophys Res Commun 346:415–425
Nahálková J (2015) Novel protein–protein interactions of TPPII, p53, and SIRT7. Mol Cell Biochem. doi:10.1007/s11010-015-2507-y
Nahálková J, Tomkinson B (2014) TPPII, MYBBP1A, and CDK2 form a protein–protein interaction network. Arch Biochem Biophys 564:128–135
Duensing S, Darr S, Cuevas R, Melquiot N et al (2010) Tripeptidyl Peptidase II Is required for c-MYC-induced centriole overduplication and a novel therapeutic target in c-MYC-associated neoplasms. Genes Cancer 1:883–892
Akaogi K, Ono W, Hayashi Y, Kishimoto H, Yanagisawa J (2013) MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis. BMC Cancer 13:65–77
Owen HR, Elser M, Cheung E, Gersbach M et al (2007) MYBBP1a is a novel repressor of NF-kappaB. J Mol Biol 366:725–736
Perrera C, Colombo R, Valsasina B, Carpinelli P (2010) Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase. J Biol Chem 285:11775–11785
Owa T, Yoshino H, Yoshimatsu K, Nagasu T (2001) Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8:1487–1503
Gavioli R, Frisan T, Vertuani S, Bornkamm GW, Masucci MG (2001) C-Myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat Cell Biol 3:283–288
Ford E, Voit R, Liszt G, Magin C et al (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 20:1075–1080
Barber MF, Michishita-Kioi E, Xi Y, Tasselli L et al (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487:114–118
Karim MF, Yoshizawa T, Sato Y, Sawa T et al (2013) Inhibition of H3K18 deacetylation of Sirt7 by Myb-binding protein 1a (Mybbp1a). Biochem Biophys Res Commun 441:157–163
Polyakova O, Borman S, Grimley R, Vamathevan et al (2012) Identification of novel interacting partners of sirtuin 6. PLoS One. doi:10.1371/journal.pone.0051555
Huttlin EL, Ting L, Bruckner RJ, Gebreab F et al (2015) The BioPlex network: a systematic exploration of the human interactome. Cell 162:425–440
Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M (2010) Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol 160:305–317
Sompallae R, Stavropoulou V, Houde M, Masucci MG (2008) The MAPK signaling cascade is a central hub in the regulation of cell cycle, apoptosis and cytoskeleton remodeling by tripeptidyl-peptidase II. Gene Regul Syst Biol 2:253–265
Grass GD, Tolliver LB, Bratoeva M, Toole BP (2013) CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness. J Biol Chem 288:26089–26104
Nahálková J, Volkmann I, Aoki M, Winblad B et al (2010) CD147, a γ-secretase associated protein is upregulated in Alzheimer’s disease brain, and its cellular trafficking is affected by presenilin-2. Neurochem Int 56:67–76
Winkler E, Hobson S, Fukumori A, Dümpelfeld B et al (2009) Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human γ-secretase. Biochemistry 48:1183–1197
Sompallae R, Stavropoulou V, Houde M, Masucci MG (2008) The MAPK signaling cascade is a central hub in the regulation of cell cycle, apoptosis and cytoskeleton remodeling by tripeptidyl-peptidase II. Gene Regul Syst Biol 2:253–265
Marchenko ND, Zaika A, Moll UM (2000) Death signal-induced localization of p53 protein to mitochondria: a potential role in apoptotic signaling. J Biol Chem 275:16202–16212
Baba M, Inoue M, Itoh K, Nishizawa Y (2008) Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem Biophys Res Commun 374:111–116
Mori S, Bernardi R, Laurent A, Resnati M et al (2012) Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis and acts as a tumor suppressor. PLoS One 7:1–14
Lu W, Zhang Y, McDonald DO, Jing H et al (2014) Dual proteolytic pathways govern glycolysis and immune competence. Cell 159:1578–1590
Tsai YC, Greco TM, Cristea IM (2014) Sirtuin 7 plays a role in ribosome biogenesis and protein synthesis. Mol Cell Proteomics 13:73–83
Araki S, Izumiya Y, Rokutanda T, Ianni A et al (2015) Sirt7 contributes to myocardial tissue repair by maintaining transforming growth factor-β signaling pathway. Circulation 132:1081–1093
Liang XH, Jackson S, Seaman M, Brown K et al (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672–676
Qu X, Yu J, Bhagat G, Furuya N et al (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809–1820
Zappavigna S, Luce A, Vitale G, Merola N et al (2013) Autophagic cell death: a new frontier in cancer research. Adv Biosci Biotechnol 4:250–262
Stavropoulou V, Xie J, Henriksson M, Tomkinson B et al (2005) Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II. Cancer Res 65:1361–1368
Neganova I, Vilella F, Atkinson SP, Lloret M et al (2011) An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 29:651–659
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A et al (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233
Anastasiou D, Yu Y, Israelsen WJ, Jiang JK et al (2012) Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 8:839–847
Steták A, Veress R, Ovádi J, Csermely P et al (2007) Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res 67:1602–1608
Zhong L, D’Urso A, Toiber D, Sebastian C et al (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell 140:280–293
Sebastián C, Mostoslavsky R (2015) The role of mammalian sirtuins in cancer metabolism. Semin Cell Dev Biol 43:33–42
Sebastián C, Zwaans BM, Silberman DM, Gymrek M (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151:1185–1199
Acuña Sanhueza GA, Faller L, George B, Koffler J et al (2012) Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells. BMC Cancer 12:72–81
Zou W, Yang H, Hou X, Zhang W et al (2007) Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910 pm cells. Cancer Lett 248:211–218
Schneiderhan W, Scheler M, Holzmann KH, Marx M (2009) CD147 silencing inhibits lactate transport and reduces the malignant potential of pancreatic cancer cells in vivo and in vitro models. Gut 58:1391–1398
Hubbi ME, Hu H, Kshitiz, Gilkes DM, Semenza GL (2013) Sirtuin-7 inhibits the activity of hypoxia-inducible factors. J Biol Chem 288:20768–20775
Yu H, Ye W, Wu J, Meng X et al (2014) Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin Cancer Res 20:3434–3445
Zhang S, Chen P, Huang Z, Hu X et al (2015) Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci Rep 5:9787–9795
Geng Q, Peng H, Chen F, Luo R, Li R (2015) High expression of Sirt7 served as a predictor of adverse outcome in breast cancer. Int J Clin Exp Pathol 8:1938–1945
Singh S, Kumar PU, Thakur S, Kiran S et al (2015) Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during the progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells. Tumour Biol 36:6159–6171
Malik S, Villanova L, Tanaka S, Aonuma M et al (2015) SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors. Sci Rep 5:9841–9850
Huber K, Superti-Furga G (2011) After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders. Bioorg Med Chem 19:3616–3624
Jung ES, Choi H, Song H, Hwang YJ et al (2016) p53-dependent SIRT6 expression protects Aβ42-induced DNA damage. Sci Rep. doi:10.1038/srep25628
Levine AJ, Hu W, Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13:1027–1036
Vetrivel KS, Zhang X, Meckler X, Cheng H et al (2008) Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta. J Biol Chem 283:19489–19498
Naruhashi K, Kadomatsu K, Igakura T, Fan QW et al (1997) Abnormalities of sensory and memory functions in mice lacking Bsg gene. Biochem Biophys Res Commun 236:733–737
Oláh J, Vincze O, Virók D, Simon D et al (2011) Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, β-amyloid, and α-synuclein. J Biol Chem 286:34088–34100
Verdaguer E, García-Jordà E, Canudas AM, Domínguez E et al (2002) Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry. NeuroReport 13:413–416
Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L et al (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549–561
Driver JA (2012) Understanding the link between cancer and neurodegeneration. J Geriatr Oncol 3:58–67
Copani A, Condorelli F, Caruso A, Vancheri CA et al (1999) Mitotic signaling by beta-amyloid causes neuronal death. FASEB J 13:2225–2234
Raspe MA (2011) Peptidases in antigen processing and neurodegenerative diseases. http://www.dare.uva.nl/document/2/87421. Accessed 3 May 2016
Spilman P, Podlutskaya N, Hart MJ, Debnath J et al (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease. PLoS One. doi:10.1371/journal.pone.0009979
Caccamo A, Maldonado MA, Majumder S, Medina DX et al (2011) Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem 286:8924–8932
Rose C, Vargas F, Facchinetti P, Bourgeat P et al (1996) Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 380:403–409
Noble F, Roques BP (2006) Cholecystokinin peptides in brain function. In Lajtha A, Lim R (eds) Handbook of neurochemistry and molecular neurobiology. 3rd edn. Springer, Berlin, Reference US, p 545–571
Facchinetti P, Rose C, Rostaing P, Triller A, Schwartz JC (1999) Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain. Neuroscience 88:1225–1240
Donehower LA (2002) Does p53 affect organismal aging? J Cell Physiol 192:23–33
Ono W, Hayashi Y, Yokoyama W, Kuroda T et al (2014) The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption. J Biol Chem 289:4928–4940
Kawahara TL, Michishita E, Adler AS, Damian M et al (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-dependent gene expression and organismal life span. Cell 136:62–74
George B, Horn D, Bayo P, Zaoui K et al (2015) Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer. Cancer Lett 358:191–199
Kida Y, Goligorsky MS (2016) Sirtuins, cell senescence, and vascular aging. Can J Cardiol. doi:10.1016/j.cjca.2015.11.022
Mostoslavsky R, Chua KF, Lombard DB, Pang WW et al (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124:315–329
Michishita E, McCord RA, Berber E, Kioi M et al (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452:492–496
Kanfi Y, Naiman S, Amir G, Peshti V et al (2012) The sirtuin SIRT6 regulates lifespan in male mice. Nature 483:218–221
Li J, Xie H, Yi M, Peng L et al (2011) Expression of cyclophilin A and CD147 during skin aging. Zhong Nan Da Xue Xue Bao Yi Xu Ban 36:203–211
Huet E, Gabison E, Vallee B, Mougenot N et al (2015) Deletion of extracellular matrix metalloproteinase inducer/cd147 induces altered cardiac extracellular matrix remodeling in aging mice. J Physiol Pharmacol 66:355–366
Vakhrusheva O, Smolka C, Gajawada P, Kostin S et al (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 102:703–710
Liu JP, Chen R (2015) Stressed SIRT7: facing a crossroad of senescence and immortality. Clin Exp Pharmacol Physiol 42:567–569
Hydbring P, Larsson LG (2010) Cdk2: a key regulator of the senescence control function of Myc. Aging (Albany NY) 2:244–250
Ohtani N, Mann DJ, Hara E (2009) Cellular senescence: its role in tumor suppression and aging. Cancer Sci 100:792–797
Vakhrusheva O, Braeuer D, Liu Z, Braun T, Bober E (2008) Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging. J Physiol Pharmacol 59:201–212
Bond J, Haughton M, Blaydes J, Gire V et al (1996) Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13:2097–2104
Gire V, Wynford-Thomas D (1998) Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol 18:1611–1621
Yoshizawa T, Karim MF, Sato Y, Senokuchi T et al (2014) SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metab 19:712–721
Cioffi M, Vallespinos-Serrano M, Trabulo SM, Fernandez-Marcos PJ et al (2015) MiR-93 controls adiposity via inhibition of Sirt7 and Tbx3. Cell Rep 12:1594–1605
Stepensky P, Rensing-Ehl A, Gather R, Revel-Vilk S et al (2014) Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. Blood 125:753–761
Vadasz Z, Haj T, Kessel A, Toubi E (2013) Age-related autoimmunity. BMC Med 11:94–97
Acknowledgments
Försäkringskassan financially supported the work on this manuscript. The funding source did not have any role in the planning, interpretation of the presented information and in the making publishing decisions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nahálková, J. The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging. Mol Cell Biochem 423, 187–196 (2016). https://doi.org/10.1007/s11010-016-2836-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-016-2836-5